Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignanciesJosé María Sánchez‐Pina, María Calbacho, Mari Liz Paciello et al.|European Journal Of Haematology|2020Cited by 96
Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppressionFederico Pulido, José Ramón Arribas, Ignacio Valero et al.|Antiviral Therapy|2009Cited by 60
Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic virusesFátima Lasala, Carmen Gil, Alfonso García‐Rubia et al.|Antiviral Research|2021Cited by 22